Jinxin Fertility Group Ltd
HKEX:1951
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.09
4.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jinxin Fertility Group Ltd
Jinxin Fertility Group Ltd
Cash & Cash Equivalents
Jinxin Fertility Group Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jinxin Fertility Group Ltd
HKEX:1951
|
Cash & Cash Equivalents
¥624.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Cash & Cash Equivalents
¥1.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Cash & Cash Equivalents
¥622.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Cash & Cash Equivalents
¥4.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
17%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Cash & Cash Equivalents
¥1.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
27%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Cash & Cash Equivalents
¥1.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
29%
|
|
Jinxin Fertility Group Ltd
Glance View
Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.
See Also
What is Jinxin Fertility Group Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
624.3m
CNY
Based on the financial report for Dec 31, 2023, Jinxin Fertility Group Ltd's Cash & Cash Equivalents amounts to 624.3m CNY.
What is Jinxin Fertility Group Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-12%
Over the last year, the Cash & Cash Equivalents growth was -53%. The average annual Cash & Cash Equivalents growth rates for Jinxin Fertility Group Ltd have been -3% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
